Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Flagship Bio, Leica Announce CDx Agreement

Published: Wednesday, April 30, 2014
Last Updated: Wednesday, April 30, 2014
Bookmark and Share
Flagship Biosciences’ custom image analysis development leverages Leica Biosystems’ strong installed base in digital pathology.

Flagship Biosciences announces it has reached agreement with Leica Biosystems to allow its custom algorithms to be utilized in companion diagnostics development on the Aperio ePathology platform. The agreement allows Flagship’s quantitative analysis programs developed with pharmaceutical customers to be delivered on an existing system with a large and growing installed base. Many of these programs take several years to develop, and may coincide with a co-developed therapeutic.

“We are excited to be able to work with Leica Biosystems, the digital pathology company with the largest footprint in both the pharmaceutical industry and clinical sites,” said Dr. Steven Potts, Chief Executive Officer for Flagship Biosciences. “It is critical for our pharmaceutical customers’ quantitative algorithms to have access to a platform with the largest installed base in the market. Knowing that the quantitative pathology approaches can be delivered on the Leica systems helps to mitigate risk and difficulties in transitioning a companion diagnostic to clinical usage.”

“With the Aperio ePathology technology and the Leica BOND automated IHC/ISH staining instruments, Leica is strongly positioned as an optimal partner for companion diagnostics development,” said Michael Cusack, Senior VP and General Manager, North America at Leica Biosystems. “Flagship Biosciences’ ability to leverage Leica’s histology and scanning technology in their CLIA laboratory for companion diagnostics is exciting. This partnership further demonstrates the value of Leica’s ePathology open platform for image analysis content.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Flagship Biosciences Customizes Assay Development and Tissue Image Analysis
Flagship Biosciences and ACD collaborate to develop quantitative RNAscope® assays for pharmaceutical clinical trials in the CLIA environment.
Tuesday, April 21, 2015
Tissue-based Companion Diagnostics Alliance Formed to Address Quantitative IHC Needs in Europe
Digital pathology enables a US-based quantitative IHC provider to partner with a UK-based histopathology laboratory in virtual services in companion diagnostics.
Wednesday, December 22, 2010
Scientific News
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
CDC Updates Zika Recommendations
CDC has issued updated Zika recommendations and guidance for healthcare providers with a focus on sexual transmission.
Review of the Analysis of Haemoglobin A1c for Diabetes Diagnostics
This paper aims to clarify methods, units, quality requirements, reference and cutoff limits for hemoglobin A1c (HbA1c) and ratio of blood glucose/HbA1c on the basis of the results from Finnish quality control surveys by comparing them to the literature.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Drug - Gene 'One-Two' Punch Against Cancer
Researchers identify gene-drug combinations that, together, target and kill cancer cells while not targeting healthy cells.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
72% Rise in Metastatic Prostate Cancer
Over the 2003-2013 period metastatic cancer has increased by an average of 72%, this could be caused by lax screening, more aggressive disease or both.
Lab-Tested Diagnosis Needed When Treating Persistent Diarrhea
New PCR multiplex method makes lab testing more effective.
Biomarker for Multiple Sclerosis Detection Discovered
Winthrop-University Hospital researchers discover biomarker for multiple sclerosis detection.
Scientists Link Bipolar Disorder to Unexpected Brain Region
Researchers from The Scripps Research Institute have found that gene within the brain’s striatum could be linked to biopolar disorder.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!